Finance

Lists
KTTA:NASDAQ
Pasithea Therapeutics Corp
$0.42
+0.14%
(+0.00060) 1D
Oct 19, 11:09:27 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTA...
Open
$0.44
High
$0.44
Low
$0.41
Mkt. cap
14.05M
Avg. vol.
155.60K
Volume
7.19K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.48
Beta
0.34
Shares outstanding
33.41M
No. of employees
5
Open
$0.44
High
$0.44
Low
$0.41
Mkt. cap
14.05M
Avg. vol.
155.60K
Volume
7.19K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.48
Beta
0.34
Shares outstanding
33.41M
No. of employees
5
News stories
From web sources and news partners
About Pasithea Therapeutics Corp
CEO-
Employees5
Founded2020
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitepasithea.com
Analyst ratings
Based on 1 analyst giving stock ratings to KTTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for KTTA in the last 3 months
Highest
Current $0.42
$3.00 (+613.27%)
Average
$3.00 (+613.27%)
Lowest
$3.00 (+613.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sara Nik
H.C. Wainwright
Buy
Reiterated
$3.00
+613.3%
10/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.36M
2.74M
2.94M
3.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
3.35M
1.93M
2.03M
Operating expense
3.11M
6.09M
4.88M
5.71M
Total operating expenses
3.11M
6.09M
4.88M
5.71M
Operating income
-3.11M
-6.09M
-4.88M
-5.71M
Other non operating income
55.49K
-64.17K
1.57M
58.81K
EBT including unusual items
-3.04M
-10.11M
-2.87M
-5.27M
EBT excluding unusual items
-3.04M
-5.95M
-2.87M
-5.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.04M
-10.11M
-2.87M
-5.27M
Net profit margin
-
-
-
-
Earnings per share
-
-0.89
-0.12
-0.16
Interest and investment income
43.40K
182.13K
450.34K
410.42K
Interest expense
-
-
-
-
Net interest expenses
43.40K
182.13K
450.34K
410.42K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.93M
-5.93M
-4.72M
-5.56M
Gain or loss from assets sale
-
103.32K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps